113 related articles for article (PubMed ID: 38600662)
1. Transformation of autophagic SQSTM1 droplets to SQSTM1-dependent P-bodies.
Valionyte E; Barrow ER; Baxter CR; Herath S; Luo S
Autophagy; 2024 Apr; ():1-2. PubMed ID: 38600662
[TBL] [Abstract][Full Text] [Related]
2. Discovery of SQSTM1/p62-dependent P-bodies that regulate the NLRP3 inflammasome.
Barrow ER; Valionyte E; Baxter CR; Yang Y; Herath S; O'Connell WA; Lopatecka J; Strachan A; Woznica W; Stephenson HN; Fejer G; Sharma V; Lu B; Luo S
Cell Rep; 2024 Mar; 43(3):113935. PubMed ID: 38460129
[TBL] [Abstract][Full Text] [Related]
3. A dominant-negative regulatory mechanism of SQSTM1 droplets-based autophagy.
Valionyte E; Barrow ER; Baxter CR; Luo S
Autophagy; 2022 Apr; 18(4):935-936. PubMed ID: 35188067
[TBL] [Abstract][Full Text] [Related]
4. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy.
Jiang H; Xie Y; Lu J; Li H; Zeng K; Hu Z; Wu D; Yang J; Yao Z; Chen H; Gong X; Yu X
Autophagy; 2024 Jan; 20(1):76-93. PubMed ID: 37647255
[TBL] [Abstract][Full Text] [Related]
5. IRGM restrains NLRP3 inflammasome activation by mediating its SQSTM1/p62-dependent selective autophagy.
Mehto S; Chauhan S; Jena KK; Chauhan NR; Nath P; Sahu R; Dhar K; Das SK; Chauhan S
Autophagy; 2019 Sep; 15(9):1645-1647. PubMed ID: 31177914
[TBL] [Abstract][Full Text] [Related]
6. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
7. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system.
Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M
EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398
[TBL] [Abstract][Full Text] [Related]
8. SQSTM1, lipid droplets and current state of their lipophagy affairs.
Shroff A; Nazarko TY
Autophagy; 2023 Feb; 19(2):720-723. PubMed ID: 35799322
[TBL] [Abstract][Full Text] [Related]
9. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.
Mildenberger J; Johansson I; Sergin I; Kjøbli E; Damås JK; Razani B; Flo TH; Bjørkøy G
Autophagy; 2017 Oct; 13(10):1664-1678. PubMed ID: 28820283
[TBL] [Abstract][Full Text] [Related]
10. Vault-phagy: a phase-separation-mediated selective autophagy of vault, a non-membranous organelle.
Kurusu R; Morishita H; Komatsu M
Autophagy; 2024 Feb; 20(2):441-442. PubMed ID: 37815214
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
[TBL] [Abstract][Full Text] [Related]
12. p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways.
Christian F; Anthony DF; Vadrevu S; Riddell T; Day JP; McLeod R; Adams DR; Baillie GS; Houslay MD
Cell Signal; 2010 Oct; 22(10):1576-96. PubMed ID: 20600853
[TBL] [Abstract][Full Text] [Related]
13. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity.
Hall BS; Dos Santos SJ; Hsieh LT; Manifava M; Ruf MT; Pluschke G; Ktistakis N; Simmonds RE
Autophagy; 2022 Apr; 18(4):841-859. PubMed ID: 34424124
[TBL] [Abstract][Full Text] [Related]
15. The caspase-6-p62 axis modulates p62 droplets based autophagy in a dominant-negative manner.
Valionyte E; Yang Y; Griffiths SA; Bone AT; Barrow ER; Sharma V; Lu B; Luo S
Cell Death Differ; 2022 Jun; 29(6):1211-1227. PubMed ID: 34862482
[TBL] [Abstract][Full Text] [Related]
16. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.
Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z
Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587
[TBL] [Abstract][Full Text] [Related]
17. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
18. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
[TBL] [Abstract][Full Text] [Related]
19. p62/SQSTM1 droplets initiate autophagosome biogenesis and oxidative stress control.
Eskelinen EL; Kageyama S; Komatsu M
Mol Cell Oncol; 2021 Mar; 8(2):1890990. PubMed ID: 33855170
[TBL] [Abstract][Full Text] [Related]
20. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
